Selective depletion of HBV-infected hepatocytes by class A capsid assembly modulators requires high levels of intrahepatic HBV core protein
Dmytro Kornyeyev(Gilead Sciences (United States)), Dara Burdette(Gilead Sciences (United States)), Raju Subramanian(Gilead Sciences (United States)), Meghan Holdorf(Novartis (United States)), Ricardo Ramírez(Gilead Sciences (United States)), Zhijuan Song(Gilead Sciences (United States)), Simon P. Fletcher(Gilead Sciences (United States)), Anastasia Hyrina(Novartis (China)), Jennifer Tang(Gilead Sciences (United States)), Shiva Zaboli(Gilead Sciences (United States)), Lauri Diehl, Cameron M. Soulette(European Bioinformatics Institute), Jens Brodbeck(Revolution Medicines (United States)), Jane Tam(Gilead Sciences (United States)), Stacey Eng(Gilead Sciences (United States)), Abhishek Aggarwal(Amazon (Germany)), Christina Moon(Gilead Sciences (United States)), Qin Yue(Gilead Sciences (United States))
Cited by 6
Related Papers
Genomic basis for RNA alterations in cancer
|Nature|2020|426
Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
|Drug Metabolism and Disposition|2002|346
Effects of Fibrates on Metabolism of Statins in Human Hepatocytes
|Drug Metabolism and Disposition|2002|325
Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation
|Proceedings of the National Academy of Sciences|2015|243
Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses
|Nature Communications|2016|230